These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10768278)

  • 1. Oxygen-mediated pulmonary vasodilation and plasma levels of endothelin-1, atrial natriuretic peptide and cyclic GMP in patients with left-to-right shunt and pulmonary hypertension.
    Gorenflo M; Bettendorf M; Ulmer HE; Brockmeier K
    Z Kardiol; 2000 Feb; 89(2):100-8. PubMed ID: 10768278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary vasoreactivity and vasoactive mediators in children with pulmonary hypertension.
    Gorenflo M; Bettendorf M; Brockmeier K; Ulmer HE
    Z Kardiol; 2000 Nov; 89(11):1000-8. PubMed ID: 11149265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation.
    Wiedemann R; Ghofrani HA; Weissmann N; Schermuly R; Quanz K; Grimminger F; Seeger W; Olschewski H
    J Am Coll Cardiol; 2001 Oct; 38(4):1130-6. PubMed ID: 11583893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma atrial natriuretic peptide levels in children with cardiac diseases: correlation with cGMP levels and haemodynamic parameters.
    Weil J; Strom TM; Brangenberg R; Sebening W; Haufe M; Lang RE; Bidlingmaier F; Gerzer R
    Horm Res; 1987; 28(1):64-70. PubMed ID: 2834283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock.
    Hartemink KJ; Groeneveld AB; de Groot MC; Strack van Schijndel RJ; van Kamp G; Thijs LG
    Crit Care Med; 2001 Jan; 29(1):80-7. PubMed ID: 11176165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma cyclic guanosine monophosphate concentrations in children with high levels of circulating atrial natriuretic peptide.
    Weil J; Gerzer R; Strom T; Lang RE; Döhlemann C; Knorr D; Bidlingmaier F
    Pediatrics; 1987 Oct; 80(4):545-8. PubMed ID: 2821478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide concentrations in children with pulmonary hypertension: correlation with hemodynamic measurements.
    Tunaoglu FS; Olgunturk FR; Gokcora N; Turkyilmaz C; Gurbuz F
    Pediatr Cardiol; 1994; 15(6):288-95. PubMed ID: 7838802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot.
    Hayabuchi Y; Matsuoka S; Kuroda Y
    Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma levels of atrial natriuretic peptide, cyclic guanosine monophosphate and renin following 7.5% NaCl + 6% hydroxyethyl starch or Ringer's lactate. A comparative study of 6 normal subjects].
    Furtwängler W; Balogh D; Pomaroli A; Koller J; Wieser C; Mair P
    Anaesthesist; 1990 Oct; 39(10):499-504. PubMed ID: 1703729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of cyclic 3', 5'-guanosine monophosphate in patients with cirrhosis: relationship with atrial natriuretic peptide and haemodynamics.
    Kirstetter P; Moreau R; Vachiery F; Gadano A; Soupison T; Pilette C; Pussard E; Cailmail S; Takahashi H; Lebrec D
    J Gastroenterol Hepatol; 1997 Mar; 12(3):233-6. PubMed ID: 9142641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure.
    Tsutamoto T; Kanamori T; Wada A; Kinoshita M
    J Am Coll Cardiol; 1992 Sep; 20(3):541-6. PubMed ID: 1324959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Levels of plasma endothelin, nitric oxide and atrial natriuretic peptide after cardiopulmonary bypass and influence of inhaled nitric oxide in patients with ventricular septal defect and pulmonary hypertension].
    Jiang H; Zhang R; Gong H; Ma Z; Li X; Song H
    Zhonghua Wai Ke Za Zhi; 2002 Apr; 40(4):290-3. PubMed ID: 12133363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect.
    Nagaya N; Nishikimi T; Uematsu M; Kyotani S; Satoh T; Nakanishi N; Matsuo H; Kangawa K
    Am Heart J; 1998 Aug; 136(2):297-301. PubMed ID: 9704693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolites of the L-arginine-NO pathway in patients with left-to-right shunt.
    Gorenflo M; Zheng C; Pöge A; Bettendorf M; Werle E; Fiehn W; Ulmer HE
    Clin Lab; 2001; 47(9-10):441-7. PubMed ID: 11596905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Values of atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in cardioversion].
    Lechleitner P; Genser N; Hauptlorenz S; Putensen C; Mitterschiffthaler G; Artner-Dworzak E; Puschendorf B; Dienstl F
    Z Kardiol; 1991 Sep; 80(9):574-9. PubMed ID: 1661054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous nitric oxide production and atrial natriuretic peptide biological activity in infants undergoing cardiac operations.
    Seghaye MC; Duchateau J; Bruniaux J; Demontoux S; Détruit H; Bosson C; Lecronier G; Mokhfi E; Serraf A; Planché C
    Crit Care Med; 1997 Jun; 25(6):1063-70. PubMed ID: 9201062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: responders versus nonresponders.
    Ghofrani HA; Wiedemann R; Rose F; Weissmann N; Schermuly RT; Quanz K; Grimminger F; Seeger W; Olschewski H
    Eur Respir J; 2002 Apr; 19(4):664-71. PubMed ID: 11998996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma endothelin-1 level in chronic obstructive pulmonary disease: relationship with natriuretic peptide.
    Fujii T; Otsuka T; Tanaka S; Kanazawa H; Hirata K; Kohno M; Kurihara N; Yoshikawa J
    Respiration; 1999; 66(3):212-9. PubMed ID: 10364736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.